The Mass Spectrometry (MS) Core of the Washington University Diabetes Research Center (DRC) increases DRC efficiency and cost effectiveness by performing MS analyses for affiliated investigators. The MS Core provides state-of-the-art MS services to determine structures and to quantitate amounts of diabetes-related biomolecules. The MS Core provides centralized, standardized analytical procedures that permit study of molecular mechanisms of the pathogenesis of diabetes mellitus, its risk factors, and its complications, including the metabolic syndrome, obesity, atherosclerosis, and increased susceptibility to infections. Speciflc objectives of the DRC MS Core are: 1. To provide training to students and fellows in principles of MS and use of MS systems, e.g., gas chromatography (GC)/MS, isotope ratio (IR)/MS, electrospray ionization (ESI)/tandem MS, and matrix assisted laser desorption ionization (MALDI)/time of fiight/(TOF)/MS in analyses of diabetes-related biomolecules. To develop new MS methods for structural identification and quantitation of molecules involved in diabetes, its risk factors and complications, and related physiologic and pathophysiologic events. To perform service MS analyses, e.g. quantitation of target analytes and obtaining spectra for structural i identification, for DRTC Investigators. To assist DRC-affiliated investigators in developing MS assays. To provide consultation in interpreting MS data. To develop and disseminate new approaches in biomedical MS that are applicable to diabetes research. To provide and maintain functional MS systems for use in diabetes research. To perform collaborative diabetes research studies involving MS Core staff requiring specialized expertise, e.g.. Stable Isotope Labeling in Cell Culture (SILAC), Stable Isotpe Labeling Tandem Mass Spectrometry (SILT), characterization of post-translational modifications or protein-protein interactions, or studies of complex lipids that require de novo structure determination. 9. To reduce diabetes research costs by providing centralized MS services at a fraction of the cost of commercial MS services or of maintaining instruments in the laboratories of individual investigators.

Public Health Relevance

The DRC MS Core employs the power of mass spectrometry to study biochemical and metabolic pathways that are altered in diabetes and in its risk factors and complications, including obesity, cardiovascular disease, and increased suscpetibility to infections, which cause morbidity and accelerate mortality. Insight into their mechanisms may lead to more effective means to prevent or treat them.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK020579-37
Application #
8625739
Study Section
Special Emphasis Panel (ZDK1-GRB-S)
Project Start
Project End
Budget Start
2013-12-01
Budget End
2014-11-30
Support Year
37
Fiscal Year
2014
Total Cost
$191,471
Indirect Cost
$65,503
Name
Washington University
Department
Type
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Evans, Trent D; Jeong, Se-Jin; Zhang, Xiangyu et al. (2018) TFEB and trehalose drive the macrophage autophagy-lysosome system to protect against atherosclerosis. Autophagy 14:724-726
Lin, Meei-Hua; Miller, Joseph B; Kikkawa, Yamato et al. (2018) Laminin-521 Protein Therapy for Glomerular Basement Membrane and Podocyte Abnormalities in a Model of Pierson Syndrome. J Am Soc Nephrol 29:1426-1436
Sidhu, Rohini; Mikulka, Christina R; Fujiwara, Hideji et al. (2018) A HILIC-MS/MS method for simultaneous quantification of the lysosomal disease markers galactosylsphingosine and glucosylsphingosine in mouse serum. Biomed Chromatogr 32:e4235
Liu, Hui; Jin, Hongjun; Han, Junbin et al. (2018) Upregulated Sphingosine 1-Phosphate Receptor 1 Expression in Human and Murine Atherosclerotic Plaques. Mol Imaging Biol 20:448-456
Wang, Songyan; Oestricker, Lauren Z; Wallendorf, Michael J et al. (2018) Cholinergic signaling mediates the effects of xenin-25 on secretion of pancreatic polypeptide but not insulin or glucagon in humans with impaired glucose tolerance. PLoS One 13:e0192441
Turk, John; White, Tayleur D; Nelson, Alexander J et al. (2018) iPLA2? and its role in male fertility, neurological disorders, metabolic disorders, and inflammation. Biochim Biophys Acta Mol Cell Biol Lipids :
Chondronikola, Maria; Magkos, Faidon; Yoshino, Jun et al. (2018) Effect of Progressive Weight Loss on Lactate Metabolism: A Randomized Controlled Trial. Obesity (Silver Spring) 26:683-688
Higgins, Cassandra B; Zhang, Yiming; Mayer, Allyson L et al. (2018) Hepatocyte ALOXE3 is induced during adaptive fasting and enhances insulin sensitivity by activating hepatic PPAR?. JCI Insight 3:
Cahill, Alison G; Haire-Joshu, Debra; Cade, W Todd et al. (2018) Weight Control Program and Gestational Weight Gain in Disadvantaged Women with Overweight or Obesity: A Randomized Clinical Trial. Obesity (Silver Spring) 26:485-491
Sato, Chihiro; Barthélemy, Nicolas R; Mawuenyega, Kwasi G et al. (2018) Tau Kinetics in Neurons and the Human Central Nervous System. Neuron 97:1284-1298.e7

Showing the most recent 10 out of 654 publications